activating transcription factor-4 inducers (Ajinomoto Pharmaceuticals/University of Tokushima)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameactivating transcription factor-4 inducers (Ajinomoto Pharmaceuticals/University of Tokushima)
Drug Alias NameATF4 inducers (Ajinomoto Pharmaceuticals/University of Tokushima)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclic AMP-dependent transcription factor ATF-4 stimulants
TargetsCyclic AMP-dependent transcription factor ATF-4
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEa Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEa Pharma Co LtdTokushima University
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A